Weiwei Weng
Impact in
- Cancer Research top 2%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Molecular Biology top 10%
- RNA modifications and cancer
- Circular RNAs in diseases
- RNA Research and Splicing
- Epigenetics and DNA Methylation
- Ubiquitin and proteasome pathways
Papers in
-
- RNA modifications and cancer 9
- Circular RNAs in diseases 5
- Oncology 18
- Pancreatic and Hepatic Oncology Research 5
- Co-authors
- Midie Xu (32 shared papers)Cong Tan (27 shared papers)Weiqi Sheng (29 shared papers)Qiongyan Zhang (14 shared papers)Shujuan Ni (23 shared papers)Xiang Du (8 shared papers)Dan Huang (23 shared papers)Yong Wu (8 shared papers)
- Journals
- Cancer Management and Research (3 papers)Journal of Cancer (3 papers)OncoTargets and Therapy (2 papers)Journal of Hematology & Oncology (2 papers)BMC Cancer (2 papers)
- Partner nations
- ChinaUnited States
In The Last Decade
Weiwei Weng
46 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 93
- Cancer Research 964
- Molecular Biology 1.2k
- Oncology 362
- Pulmonary and Respiratory Medicine 241
- Pathology and Forensic Medicine 116
Countries citing papers authored by Weiwei Weng
This map shows the geographic impact of Weiwei Weng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiwei Weng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiwei Weng more than expected).
Fields of papers citing papers by Weiwei Weng
This network shows the impact of papers produced by Weiwei Weng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiwei Weng. The network helps show where Weiwei Weng may publish in the future.
Co-authors
The 25 scholars most cited alongside Weiwei Weng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 47 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 276 | |
| 2 | 2016 | 206 | |
| 3 | 2015 | 144 | |
| 4 | 2017 | 117 | |
| 5 | 2018 | 103 | |
| 6 | 2018 | 95 | |
| 7 | 2016 | 51 | |
| 8 | 2018 | 46 | |
| 9 | 2018 | 42 | |
| 10 | 2022 | 38 | |
| 11 | 2017 | 38 | |
| 12 | 2019 | 38 | |
| 13 | 2018 | 38 | |
| 14 | OTUB1 promotes tumor invasion and predicts a poor prognosis in gastric adenocarcinoma. | 2016 | 36 |
| 15 | 2020 | 36 | |
| 16 | 2017 | 30 | |
| 17 | 2019 | 27 | |
| 18 | 2016 | 22 | |
| 19 | 2019 | 21 | |
| 20 | 2018 | 19 |
About Weiwei Weng
Weiwei Weng is a scholar working on Molecular Biology, Oncology, Cancer Research, Pulmonary and Respiratory Medicine and Surgery, having authored 47 papers that have together received 1.6k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (11 papers), RNA modifications and cancer (9 papers), Genetic factors in colorectal cancer (6 papers), Ferroptosis and cancer prognosis (6 papers), Circular RNAs in diseases (5 papers), Gastric Cancer Management and Outcomes (5 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers) and Pancreatic and Hepatic Oncology Research (5 papers). The work is most often cited by research in Cancer Research (964 citations), Molecular Biology (1.2k citations), Oncology (362 citations), Pulmonary and Respiratory Medicine (241 citations) and Pathology and Forensic Medicine (116 citations). Weiwei Weng has collaborated with scholars based in China and United States. Frequent co-authors include Midie Xu, Cong Tan, Weiqi Sheng, Qiongyan Zhang, Shujuan Ni, Xiang Du, Dan Huang, Yong Wu, Ping Wei and Meng Zhang. Their work appears in journals such as Cancer Management and Research, Journal of Cancer, OncoTargets and Therapy, Journal of Hematology & Oncology and BMC Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.